Amniotic Fluid Embolism (AFE): Understanding, Management, and Prevention

Maternal 911

In this article...

Overview of Amniotic Fluid Embolism (AFE) Amniotic Fluid Embolism (AFE) is a rare but life-threatening obstetric emergency. It occurs when amniotic fluid, fetal cells, or tissue enter the maternal bloodstream, triggering an intense immune and clotting reaction. This can cause cardiovascular collapse, respiratory failure, and severe bleeding. While rare, AFE has high maternal and fetal ... Read more

Overview of Amniotic Fluid Embolism (AFE)

Amniotic Fluid Embolism (AFE) is a rare but life-threatening obstetric emergency. It occurs when amniotic fluid, fetal cells, or tissue enter the maternal bloodstream, triggering an intense immune and clotting reaction. This can cause cardiovascular collapse, respiratory failure, and severe bleeding. While rare, AFE has high maternal and fetal mortality rates, making rapid recognition and emergency management essential.

Incidence and Risk Factors of AFE

AFE affects approximately 1 in 40,000 to 1 in 80,000 pregnancies worldwide. It may develop during labor, delivery, or shortly after birth. Risk factors include:

  • Advanced maternal age
  • Multiple pregnancies
  • Cesarean section
  • Placenta previa or preeclampsia
  • Rapid or tumultuous labor

However, AFE can also occur without any known risk factors, highlighting the importance of preparedness in every delivery setting.

Pathophysiology of Amniotic Fluid Embolism

The exact cause of Amniotic Fluid Embolism (AFE) remains unclear. When amniotic fluid enters the maternal circulation, it may trigger a severe inflammatory response, causing pulmonary vasospasm, hypoxia, and cardiovascular collapse. The activation of coagulation pathways can lead to disseminated intravascular coagulation (DIC) and uncontrolled bleeding.

Clinical Signs and Symptoms

AFE often presents suddenly and dramatically during labor or immediately postpartum. Typical symptoms include:

  • Sudden shortness of breath or chest pain
  • Hypotension and cardiovascular collapse
  • Cyanosis (bluish skin discoloration)
  • Altered mental status or loss of consciousness
  • Heavy postpartum bleeding due to DIC

These symptoms can progress rapidly, and immediate recognition is vital for survival.

Diagnosis of Amniotic Fluid Embolism

There is no single diagnostic test for AFE. Diagnosis is based on clinical presentation — sudden cardiovascular and respiratory failure combined with coagulopathy in a pregnant or postpartum woman.
Supportive investigations such as blood tests, coagulation profiles, and imaging help exclude other possible causes but do not confirm AFE.

Emergency Management of AFE

When AFE is suspected, immediate resuscitation is critical. Management focuses on stabilizing the airway, breathing, and circulation (ABCs):

  • Provide 100% oxygen and secure the airway
  • Initiate IV fluids and vasopressors to support blood pressure
  • Administer blood products as needed
  • Coordinate with obstetric, anesthesia, and critical care teams

Rapid, multidisciplinary teamwork improves both maternal and fetal outcomes.

Obstetric and Hematologic Support

If AFE occurs during labor, urgent delivery (often via emergency cesarean section) may be necessary to improve oxygenation for both mother and baby.
Managing DIC and massive bleeding requires early and aggressive transfusion therapy, including packed red blood cells, plasma, platelets, and cryoprecipitate.

Prognosis and Recovery

In the past, AFE mortality rates reached up to 80%. Today, with rapid recognition and improved intensive care, survival rates have increased to 50–70%. Neurological outcomes depend on how quickly oxygenation and circulation are restored.

Prevention and Awareness

While AFE cannot be fully prevented, awareness and preparedness are essential. Hospitals should establish rapid-response protocols for maternal emergencies. Regular simulation drills, staff education, and easy access to blood products and critical care resources can save lives.

Conclusion: Acting Fast Saves Lives

Amniotic Fluid Embolism (AFE) remains one of the most challenging obstetric emergencies. Preparedness, early recognition, and coordinated multidisciplinary response are key to survival. Every second counts — and awareness is the first step toward saving lives.

For more information, visit the CDC’s Maternal Mortality Review Program

Maternal 911 Education Systems, LLC includes an obstetrician-gynecologist and a women’s healthcare nurse practitioner specializing in emergency obstetrics, intrapartum, and postpartum safety. Passionate about maternal health education, Maternal 911 advocates for evidence-based practice and interdisciplinary training.

Educational use only — not a substitute for clinical judgment or local protocols.
Click here to contact us with any questions.

Maternal 911

Maternal 911 is a premier provider of educational solutions for the healthcare workforce, equipping organizations and their teams with comprehensive resources and tools focused on maternal health.